###begin article-title 0
MDM4 (MDMX) and its Transcript Variants
###end article-title 0
###begin p 1
###xml 166 171 <span type="species:ncbi:9606">human</span>
MDM family proteins are crucial regulators of the oncosuppressor p53. Alterations of their gene status, mainly amplification events, have been frequently observed in human tumors.
###end p 1
###begin p 2
###xml 54 59 <span type="species:ncbi:9606">human</span>
MDM4 is one of the two members of the MDM family. The human gene is located on chromosome 1 at q32-33 and codes for a protein of 490aa. In analogy to MDM2, besides the full-length mRNA several transcript variants of MDM4 have been identified. Almost all variants thus far described derive from a splicing process, both through canonical and aberrant splicing events. Some of these variants are expressed in normal tissues, others have been observed only in tumor samples. The presence of these variants may be considered a fine tuning of the function of the full-length protein, especially in normal cells. In tumor cells, some variants show oncogenic properties.
###end p 2
###begin p 3
This review summarizes all the different MDM4 splicing forms thus far described and their role in the regulation of the wild type protein function in normal and tumor cells. In addition, a description of the full-length protein structure with all known interacting proteins thus far identified and a comparison of the MDM4 variant structure with that of full-length protein are presented. Finally, a parallel between MDM4 and MDM2 variants is discussed.
###end p 3
###begin title 4
Key Words
###end title 4
###begin title 5
FULL-LENGTH MDM4
###end title 5
###begin title 6
Protein Domains
###end title 6
###begin p 7
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2">2</xref>
###xml 576 580 576 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4</italic>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2">2</xref>
###xml 936 937 936 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R2">2</xref>
###xml 944 948 944 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4</italic>
###xml 1124 1125 1124 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 1124 1125 1124 1125 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F1">1</xref></bold>
###xml 4 10 <span type="species:ncbi:10090">murine</span>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 214 219 <span type="species:ncbi:10090">mouse</span>
###xml 428 433 <span type="species:ncbi:9606">human</span>
###xml 570 575 <span type="species:ncbi:9606">human</span>
###xml 1010 1015 <span type="species:ncbi:10090">mouse</span>
The murine Mdm4 protein (transformed mouse 3T3 cell double minute 4), formerly named Mdmx, has been identified in 1996 as a p53 binding protein [1]. It shows significant homology with the Mdm2 protein (transformed mouse 3T3 cell double minute 2), the best known negative regulator of p53 (Trp53, transformation related protein 53), particularly in the N-terminal p53-binding domain and in the C-terminus of the protein [1]. The human homolog MDM4, (Mdm4 p53 binding protein homolog) has been localized on chromosome 1q32 [2]. Northern blot analysis has revealed a 10-kb human MDM4 transcript expressed in almost all tissues although with different proportions [2]. The mRNA comprises 11 exons, with the first AUG codon in the second exon. Despite the presence of additional in-frame AUG codons at positions 46, 53 and 61 (starting from the first AUG), there is no evidence of alternative transcripts originating from these start sites [2]. The MDM4 cDNA codes for a protein of 490 amino acids (aa) (489 in the mouse), with the exon 11 coding for the C-terminal last 189 aa. The structure of the protein is depicted in Fig. (1).
###end p 7
###begin p 8
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">3</xref>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R4">4</xref>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R5">5</xref>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R6">6</xref>
###xml 679 680 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R7">7</xref>
###xml 681 682 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">8</xref>
###xml 911 912 911 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R9">9</xref>
###xml 1044 1045 1044 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R3">3</xref>
###xml 1291 1292 1291 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R8">8</xref>
###xml 1294 1296 1294 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R10">10</xref>
###xml 1297 1299 1297 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R13">13</xref>
###xml 20 25 <span type="species:ncbi:9606">human</span>
It comprises a p53 (human TP53, tumor protein 53) binding domain (BD) between amino acids 24 and 108 according to the NMR study of the analogous MDM2 (Mdm2 p53 binding protein homolog) region [3]. The residues of MDM2 involved in p53 binding [4] are totally conserved in MDM4 (G58, D68, V75, C77 corresponding to MDM4 G57, D67, V74, C76) and mutation of the first of them abolishes p53 binding to MDM4 [5] suggesting high similarity in the association of MDM2 and MDM4 to p53 [6]. However, the crystal structure of the p53-binding domain of MDM4 in complex with a peptide derived from the p53 N-terminus (aa 17-37), has revealed differences between MDM4 and MDM2 binding to p53 [7,8]. Particularly, the hydrophobic cleft on which the transactivation domain of p53 binds is smaller in MDM4 than in MDM2. Coarse graining simulations have confirmed that recognition of p53 is favored in MDM2 with respect to MDM4 [9]. Further, the N-terminal lid of MDM2 (aa 16-24) that competes for p53 binding under some circumstances, is not conserved in MDM4 [3]. As a further confirmation of the divergence existing between the p53 binding domains of MDM4 and MDM2, the drug-like small molecule Nutlin-3a disrupts the MDM4-p53 complex at a concentration much higher than that required to disrupt MDM2-p53 [8, 10-13].
###end p 8
###begin p 9
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R14">14</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R15">15</xref>
###xml 241 248 241 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">16</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">17</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R21">21</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R22">22</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R24">24</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R20">20</xref>
###xml 647 649 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R25">25</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R21">21</xref>
###xml 898 900 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R22">22</xref>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R24">24</xref>
The other region with high similarity between MDM4 and MDM2 is the C-terminus containing the RING finger motif (aa 437-477). Whereas this motif mediates ubiquitin ligase activity in MDM2, [14, 15] it doesn't confer the same function to MDM4 in vivo [16]. Nevertheless, various groups have shown the ability of MDM4 to potentiate E3 ubiquitin ligase activity of MDM2 and/or to restore function of inactive mutant MDM2 suggesting that MDM4 can contribute to the MDM2 E3 function [17-21]. In addition, the RING finger mediates MDM4-MDM2 association [22-24] although the extreme C-terminus of both proteins is necessary too for their interaction [20, 25]. The residues involved in MDM2-MDM4 interaction have been recognized in some hydrophobic residues (of the RING finger of MDM2) [21]. In addition, mutation of the amino acids disrupting the RING finger structure abolishes this association as well [22, 24].
###end p 9
###begin p 10
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 387 389 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R26">26</xref>
Within the RING finger a potential nuclear localization signal has been mapped (aa 465-469) composed of a stretch of basic amino acids (RRLKK) [1]. This site has been suggested to mediate nuclear translocation of MDM4 after DNA damage. Indeed, point mutation of a lysine in this stretch abolishes nuclear translocation of MDM4 and its binding to the cytoplasmic receptor importin alpha [26].
###end p 10
###begin p 11
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R27">27</xref>
###xml 448 450 448 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sub>
###xml 451 453 451 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sub>
###xml 455 457 455 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25</sub>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R28">28</xref>
Another recognizable region in MDM4 is the Zinc finger motif between aa 300 and 328. This is a C4 Zinc finger motif of the RanBP2-type Zinc finger family. Particularly, it can be assigned to the related polypeptide family termed Npl4 Zinc finger (NZF), characterized by the presence of only two residues between the first two cysteines [27]. The RanBP2/ NZF fingers have been described as ubiquitin recognition motifs, but the lack in MDM4 of the T13F14/M25 residues would exclude this function [28] leaving unknown the function of this domain.
###end p 11
###begin p 12
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R29">29</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R29">29</xref>
Close to the Zinc finger motif, it is present a tetrapeptide that represents a canonical caspase cleavage signal (aa 357-361, DVPD) [29]. Indeed, this site is sensitive to caspase activity. The caspase cleavage of MDM4 at this site has been shown to affect protein stability [29].
###end p 12
###begin p 13
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">16</xref>
The central region of MDM4 is rich in acidic residues and for this reason is indicated as acidic domain [16]. So far no specific activities have been attributed to this portion of the protein.
###end p 13
###begin p 14
Finally, some residues of MDM4 have been recognized as specific targets of post translational modification:
###end p 14
###begin p 15
###xml 0 13 0 13 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K254 and K379</underline>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R30">30</xref>
K254 and K379 have been identified as SUMO-1 targets. These modifications do not alter MDM4 stability and subcellular localization nor its inhibitory activity toward p53 transcriptional function, leaving unknown the role of these sumoylations [30];
###end p 15
###begin p 16
###xml 0 3 0 3 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S96</underline>
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p34</sup>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R31">31</xref>
S96 is phosphorylated by cyclin-dependent kinase 1 (CDK1/Cdc2p34). The mutation S96A redistributes MDM4 in the nucleus suggesting that the phosphorylation of this site may affect MDM4 subcellular localization [31];
###end p 16
###begin p 17
###xml 0 4 0 4 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S289</underline>
###xml 185 187 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R32">32</xref>
S289 is phosphorylated by Casein Kinase 1alpha (CK1alpha) This modification strengthens the association between MDM4 and p53 and the inhibition of p53 transcriptional function by MDM4 [32];
###end p 17
###begin p 18
###xml 0 4 0 4 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S342</underline>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">33</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34">34</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">33</xref>
###xml 303 305 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">33</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R35">35</xref>
###xml 323 331 323 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 428 435 428 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 501 502 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</sup>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">33</xref>
S342 is phosphorylated by Checkpoint Kinases 1 and 2 (Chk1/Chk2) [33, 34]. This modification, as that of the S367 site (see below), is present in U2OS cell line under normal growth conditions but is highly increased after IR [33]. The phosphorylation of this site mediates enhanced degradation of MDM4 [33-35]. Comparative in vitro assays indicate that Chk1 is more efficient than Chk2 in inducing this phosphorylation although in vivo the knockout (KO) of Chk2 abolishes the DNA-damage induced Ser342P [33];
###end p 18
###begin p 19
###xml 0 4 0 4 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S367</underline>
###xml 41 43 41 43 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">33</xref>
###xml 45 47 45 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34">34</xref>
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">36</xref>
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R37">37</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">33</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34">34</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">36</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R38">38</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R33">33</xref>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R35">35</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R37">37</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R38">38</xref>
S367 is phosphorylated by Chk1/Chk2/Akt [33, 34, 36, 37]. As for S342, the phosphorylation at this MDM4 site is detectable also under normal growth conditions although DNA damage strongly induces it [33, 34, 36, 38]. Phosphorylation at this site regulates MDM4 stability [33-35, 37, 38] and induces binding of different 14-3-3 isoforms to MDM4 (See the following 14-3-3 paragraph);
###end p 19
###begin p 20
###xml 0 4 0 4 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S403</underline>
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R35">35</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R35">35</xref>
S403 is phosphorylated by ataxia telangiectasia mutated (ATM) [35]. It is induced by DNA damage and the S403A MDM4 mutant is more stable than the wild-type (wt) protein indicating also for this phosphorylation a role in MDM4 degradation [35].
###end p 20
###begin title 21
MDM4 INTERACTIONS
###end title 21
###begin title 22
P53 Family Members
###end title 22
###begin p 23
###xml 72 73 72 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 268 271 268 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 264 271 264 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mdm4<sup>-/-</sup></italic>
###xml 348 353 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trp53</italic>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R39">39</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R41">41</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R42">42</xref>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
MDM4 has been identified by Jochemsen's group as a p53 binding protein [1]. P53 is one of the main human oncosuppressor genes and is involved in a plethora of cell functions. The crucial role of MDM4 in the regulation of p53 has been assessed by the KO Mdm4 mice. Mdm4-/- mice die in utero but their death is rescued by concomitant deletion of the Trp53 gene [39-41]. At the molecular levels, the different activities exerted by MDM4 and MDM2 toward p53 have led to the proposal of three different models of inhibition of p53 function, still debated in the scientific community [42].
###end p 23
###begin p 24
###xml 178 180 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R43">43</xref>
###xml 181 183 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R44">44</xref>
###xml 203 210 199 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 384 386 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R44">44</xref>
###xml 387 389 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R45">45</xref>
###xml 479 481 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R44">44</xref>
In addition to p53, the BD of MDM4 is probably responsible for the association of MDM4 to the other p53 family member, p73alpha although this has not been experimentally proven [43,44]. On the contrary, in vivo binding of MDM4 to p63alpha and p63gamma both the TA and DN variants, have been excluded by two groups suggesting the existence of differences among the p53 family members [44,45]. The activity of MDM4 toward p73alpha confirms its transcriptional inhibitory function [44].
###end p 24
###begin title 25
MDM2
###end title 25
###begin p 26
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R18">18</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R21">21</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R23">23</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R24">24</xref>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R17">17</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R21">21</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R24">24</xref>
###xml 644 647 644 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-/-</sup>
###xml 640 647 640 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mdm4<sup>-/-</sup></italic>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R46">46</xref>
###xml 963 965 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">16</xref>
###xml 602 607 <span type="species:ncbi:10090">mouse</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
The binding between MDM4 and MDM2 leads to the formation of a heterodimer, which possesses higher stability in comparison to the homodimer of each protein [18, 21, 23]. In MCF7, majority of MDM4 is in complex with MDM2 suggesting that the heterodimer is the predominant form into the cell [24]. However, the function of the heterodimer has not been completely clarified. Indeed, whereas a growing body of evidence suggests a cooperation of MDM4 in the E3 ligase activity of MDM2 [17-21, 24], a recent report has evidenced the lower stability of a temperature-sensitive mutant p53 (p53A135V) protein in mouse embryo fibroblasts derived from Mdm4-/- mice [46] suggesting the existence of an antagonizing function of endogenous MDM4 toward the degradative activity of MDM2, at least under some conditions. In addition, it has been reported an antagonizing function of MDM4 toward MDM2-degradative activity when the levels of overexpressed MDM4 exceed those of MDM2 [16].
###end p 26
###begin title 27
14-3-3 Proteins
###end title 27
###begin p 28
###xml 248 250 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R26">26</xref>
###xml 252 254 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">36</xref>
###xml 255 257 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R38">38</xref>
###xml 458 460 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R26">26</xref>
###xml 462 464 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34">34</xref>
###xml 466 468 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">36</xref>
###xml 469 471 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R38">38</xref>
###xml 609 611 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34">34</xref>
###xml 756 758 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R26">26</xref>
###xml 760 762 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R34">34</xref>
###xml 764 766 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R38">38</xref>
###xml 792 794 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R37">37</xref>
###xml 851 853 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R36">36</xref>
The interaction of MDM4 with 14-3-3 family has emerged in recent years. Although a detailed comparison of the affinity of MDM4 to the seven 14-3-3 members has not been carried out, the 14-3-3sigma form seems the less efficient in this association [26, 36-38]. The MDM4 region involved in such interaction has been recognized in the peptide 363-369 of MDM4. Particularly, the amino acid S367 is the phosphorylable key residue responsible of this association [26, 34, 36-38]. In addition, the region surrounding residue S342 affects the binding between MDM4 and 14-3-3, at least under normal growth conditions [34]. The outcome resulting from MDM4/14-3-3 association is really puzzling: the major and more detailed effect is the nuclear degradation of MDM4 [26, 34, 38], however stabilization [37] as well as increased cytoplasmic localization of MDM4 [36] have been reported too. Whether these different results rely on the S367-phosphorylation accompanying modifications, or/and on the type of 14-3-3 isoform bound to MDM4, and/or on the DNA damage conditions, it remains to be ascertained.
###end p 28
###begin title 29
Other Proteins
###end title 29
###begin title 30
CK1alpha (Casein Kinase 1alpha)
###end title 30
###begin p 31
###xml 190 192 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R32">32</xref>
MDM4 associates to CK1alpha through a large region encompassing the acidic and the Zinc finger regions and this association has been proven necessary to the MDM4-mediated inhibition of p53 [32].
###end p 31
###begin title 32
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p34</sup>
CDK1/Cdc2p34 (Cyclin-Dependent Kinase 1)
###end title 32
###begin p 33
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R31">31</xref>
###xml 19 25 <span type="species:ncbi:10090">murine</span>
The association of murine MDM4 to the endogenous Cdc2 has been shown by means of the overexpression of MDM4. The region responsible for the association has not been mapped. It has been hypothesized that this association mediates phosphorylation of MDM4 on aa S96 that in turn affects MDM4 subcellular localization [31].
###end p 33
###begin title 34
E2F1
###end title 34
###begin p 35
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</italic>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R47">47</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R47">47</xref>
###xml 288 295 288 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R48">48</xref>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R49">49</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R48">48</xref>
###xml 86 91 <span type="species:ncbi:4932">yeast</span>
The interaction of MDM4 with this factor has been assessed by GST-pull down assay and yeast two hybrid screen [47]. These studies have indicated the MDM4 region next to the C-terminus of the BD important for this association [47]. Nevertheless, this association has not been confirmed by in vivo coimmunoprecipitation experiments [48]. A reduction of MDM4 protein levels has been reported following overexpression of E2F1 [49] although the molecular mechanisms underlying this reduction remain to be clarified as well as the biological significance of it. Conversely, the ability of MDM4 to repress E2F1 transactivation has been reported [48]. Whether the E2F1-MDM4 association is responsible for any of these effects has not been tested.
###end p 35
###begin title 36
Hausp/USP7 (Ubiquitin Specific Peptidase 7)
###end title 36
###begin p 37
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R50">50</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R50">50</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R51">51</xref>
A direct binding of the deubiquitinating enzyme Hausp with MDM4 has been described by Jochemsen's group [50]. The behavior of MDM4 deletion mutants has indicated that the p53 binding domain of MDM4 is sufficient to coimmunoprecipitate Hausp. However, a MDM4 mutant lacking this domain is still able to bind Hausp with efficiency similar to the wt-protein suggesting that another not well defined region of MDM4 may mediate Hausp binding. The binding of Hausp to MDM4 contributes to stabilize MDM4 protein levels, by counteracting its MDM2-mediated degradation. The current model suggests that in normal growing cells MDM4 levels are controlled by a balanced association with Hausp and MDM2. Under DNA damage, Hausp association to MDM4 is attenuated in an ATM dependent manner leading to a decrease of MDM4 protein levels [50,51].
###end p 37
###begin title 38
Importin alpha
###end title 38
###begin p 39
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R1">1</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R52">52</xref>
###xml 338 340 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R26">26</xref>
Within the RING finger, MDM4 possesses a stretch of basic aa that represents a putative nuclear localization signal [1]. Indeed, upon DNA damage MDM4 translocates in the nucleus, also independently of its shuttling protein MDM2 [52]. GST-pull down experiments have shown interaction of MDM4 with the cytoplasmic receptors importin alpha [26]. Point mutation of MDM4 basic amino acid, K468, impairs MDM4 binding to importin alpha and nuclear translocation after DNA damage suggesting a potential role for this association at least under some conditions.
###end p 39
###begin title 40
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</sup>
P14Arf
###end title 40
###begin p 41
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R53">53</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R55">55</xref>
###xml 254 257 254 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R55">55</xref>
###xml 289 292 289 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R54">54</xref>
The binding of MDM4 to p14ARF is controversial since different groups have published opposing results with overexpressed tagged proteins [53-55]. Definitely, it requires confirmation with the endogenous proteins. However, interference of MDM4 towards p14ARF activity [55] as well as of p14ARF towards MDM4 function [54] has been reported suggesting the potential existence of a crosstalk between these two proteins.
###end p 41
###begin title 42
P21
###end title 42
###begin p 43
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R56">56</xref>
The binding of MDM4 to the cyclin-dependent kinase inhibitor, p21 (CDKN1A), requires at least three regions, one comprising the BD, the second the central region (aa 233-322), the third encompassing the RING finger domain (aa 423-490) [56]. Whether the three regions represent all contact points or are necessary for the proper conformation of the binding pocket remains to be ascertained. The MDM4 function toward p21 promotes proteosomal turnover of p21.
###end p 43
###begin title 44
P300
###end title 44
###begin p 45
###xml 81 89 81 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R57">57</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R58">58</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R57">57</xref>
The association between MDM4 and the co-activator p300 has been assessed only by in vitro experiments [57]. However, the ability of MDM4 to interfere with p300 activity has been reported. This interference results in decrease of p300-mediated acetylated p53 [58] and in the impairment of the interaction of p300 with the transcriptional factors Smad3 and 4 that in turn invalidates the activity of these last [57].
###end p 45
###begin title 46
pRB (Retinoblastoma Protein)
###end title 46
###begin p 47
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R59">59</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R59">59</xref>
Coimmunoprecipitation experiments in tumor cell lines have shown the association between endogenous proteins MDM4 and pRB [59]. Although the MDM4 region responsible for such binding has not been mapped, the C-terminus (aa 405-490) is not required. Further, the possibility that this association is mediated by other proteins cannot be ruled out. In the report of Kitagawa's group, MDM4 counteracts MDM2-mediated degradation of pRB, thus positively regulating its protein levels and transcriptional function [59].
###end p 47
###begin title 48
S2
###end title 48
###begin p 49
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R56">56</xref>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R56">56</xref>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 274 290 274 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">unpublished data</italic>
Recently, MDM4 has been shown to interact with the subunit S2 (Rpn1) of the 26S proteasome [56]. In this report, the BD and the C-terminus regions of MDM4 are both required for the association although the C-terminus loss slightly impairs the binding [56] (Di Conza et al., unpublished data). This association is presumed to confer to MDM4 the ability to promote proteosomal degradation of the cyclin dependent inhibitor p21.
###end p 49
###begin title 50
SMAD 3 and 4
###end title 50
###begin p 51
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R57">57</xref>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R60">60</xref>
Similarly to E2F1, contradictory results have been provided about this association [57, 60]. However, an inhibitory function of MDM4 toward these two transcription factors has been reported in two independent reports.
###end p 51
###begin title 52
MDM4 Variants
###end title 52
###begin p 53
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRP53</italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R42">42</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R61">61</xref>
###xml 875 876 875 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 875 876 875 876 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F2">2</xref></bold>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 206 211 <span type="species:ncbi:9606">human</span>
###xml 263 268 <span type="species:ncbi:9606">human</span>
###xml 571 576 <span type="species:ncbi:9606">human</span>
Analysis of human tumors has evidenced aberrant expression of MDM4 in different human tumors characterized by wild type TRP53 supporting the hypothesis of an important role of MDM4 in the control of p53 in human tumorigenesis. The more frequent event observed in human tumors is the amplification of the gene [42]. In addition, the presence of shorter forms of MDM4 besides the full-length protein has emerged. The first observation derived from Jochemsen's group, which reported the presence by immunoblot (WB) analysis of at least 5 shorter MDM4 forms in a panel of 31 human tumor cell lines [61]. Only one of them, resolving at kDa 30,000, was detected in normal cells, melanocytes, suggesting the occurrence of the other forms specifically in tumor cells. Since then, 7 shorter forms of MDM4 have been characterized. All, but one, derived from alternative splicing (Fig. 2). These transcript variants are described in more details in the following paragraphs.
###end p 53
###begin title 54
MDM4-S
###end title 54
###begin p 55
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R62">62</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2b</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R16">16</xref>
###xml 918 920 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R62">62</xref>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R63">63</xref>
###xml 1119 1121 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R62">62</xref>
###xml 1123 1125 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R63">63</xref>
###xml 54 60 <span type="species:ncbi:10090">murine</span>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 86 91 <span type="species:ncbi:9606">Human</span>
###xml 538 544 <span type="species:ncbi:10090">murine</span>
Mdm4-S was the first transcript variant identified in murine and in human cells [62]. Human MDM4-S is the product of an internal deletion of 68 base pairs, occurring at the level of exon 6. This deletion produces a shift of the reading frame after codon 114 and introduces a new translation stop codon following amino acid 140 (Fig. 2b). The result of this splicing is a truncated protein that encodes for the first 114 aa of full-length (fl) MDM4 (the entire p53 binding domain) with the addition of C-terminal 26 aa residues (13 in the murine protein) [16]. In immunoblot, the MDM4-S size of 27kDa is higher than its predicted molecular mass of 15kDa, suggesting the presence of posttranslational modifications as hypothesized for fl-MDM4. In agreement with its structure, MDM4-S associates with p53. However, its affinity toward p53 is approximately 10 fold higher than that of fl-MDM4 (analyzed by GST pull down) [62, 63]. As a consequence, MDM4-S is a more potent suppressor of p53 transcriptional activity. Analysis of nuclear and cytosolic fractions indicates that endogenous MDM4-S is localized in the nucleus [62, 63]. Whether the nuclear localization of MDM4-S may be responsible, at least in part, for the enhanced inhibition of p53 has not been ascertained.
###end p 55
###begin p 56
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R62">62</xref>
###xml 640 646 640 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4-S</italic>
###xml 681 688 681 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl-MDM4</italic>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R62">62</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R64">64</xref>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R65">65</xref>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R64">64</xref>
###xml 841 843 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R65">65</xref>
###xml 915 921 915 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4-S</italic>
###xml 992 994 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R62">62</xref>
The MDM4-S-mediated impairment of p53 function has been hypothesized as the basis for its oncogenic potential [62]. In addition, the lack of other portions of fl-MDM4 protein should make MDM4-S insensitive to the regulatory modifications thus far reported, particularly those regarding the destabilization of protein levels. Although comparison of MDM4-S and fl-MDM4 protein stability has not been performed, this property would make MDM4-S even more oncogenic that fl-MDM4. In agreement with the hypothesis of higher oncogenic properties of MDM4-S in comparison to fl-MDM4, analysis of tumor cell lines and samples has evidenced levels of MDM4-S transcript exceeding those of the fl-MDM4, with a certain frequency [62, 64, 65]. On the contrary, in normal tissues the ratio MDM4-S to fl-MDM4 never exceed 1.1 with majority of values <1 [64, 65]. Interestingly, in growing cells in comparison to serum starved cells MDM4-S transcript is increased, confirming its positive role in cell growth [62].
###end p 56
###begin p 57
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4-S</italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R66">66</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R64">64</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R65">65</xref>
###xml 254 260 254 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4-S</italic>
###xml 438 447 438 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4-S do</italic>
###xml 490 494 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4</italic>
###xml 563 567 563 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4</italic>
Thus far, analysis of MDM4-S mRNA and/or protein has been evaluated in three different groups of tumor samples: in a group of 208 gliomas [66], a group of 66 primary soft tissue sarcomas (STS) [64], and a group of 57 papillary thyroid tumors (PTC) [65]. MDM4-S is detectable in 78% of the STS samples and in 91% of PTC while the frequency of its overexpression ranges from 19% to 35% in the two groups. In all three groups, the levels of MDM4-S do not correlate with increased levels of fl-MDM4 mRNA suggesting that the overexpression of MDM4-S is independent of MDM4 mRNA levels.
###end p 57
###begin p 58
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R64">64</xref>
###xml 512 518 512 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4-S</italic>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R66">66</xref>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
The analysis of association of MDM4-S overexpression with tumor properties has evidenced a significant correlation with an unfavorable prognosis of STS patients [64]. Intriguingly, in this report there is no association between MDM4-S overexpression and p53 status, suggesting that MDM4-S might exerts its function towards targets other than wt-p53. It would be interesting to investigate whether it exerts any positive regulation of mutant p53. In analogy to data reported for STS, a significant association of MDM4-S overexpression has been reported with high grade glioblastomas [66] supporting the hypothesis that MDM4-S, better than fl-MDM4, might contribute to inactivate p53.
###end p 58
###begin title 59
MDM4-A and MDM4-G
###end title 59
###begin p 60
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R67">67</xref>
MDM4-A and MDM4-G have been characterized in C33A cells [67]. Although the endogenous protein product of their transcripts has not been evidenced, the analysis of their activity has evidenced some potential interesting properties of MDM4 variants.
###end p 60
###begin p 61
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2b</xref>
###xml 70 72 70 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F2">2b</xref></bold>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R67">67</xref>
MDM4-A lacks most of the acidic region (deletion of aa 225-274) (Fig. 2b). This loss results in a strong susceptibility of this variant to the MDM2 degradative activity, pointing to an important role of this domain in the stability of fl-MDM4. Although detailed studies are necessary to clarify the mechanism that underlie MDM4-A destabilization, it has been proposed that the acidic domain of MDM4 might mask the acidic domain of MDM2 and inhibit its degradative function especially toward p53, which depends also on the presence of this domain [67]. Thus, this MDM4 variant might possess oncogenic properties by functioning in complex with MDM2 to enhance the degradative function of it.
###end p 61
###begin p 62
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2b</xref>
###xml 109 111 109 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F2">2b</xref></bold>
The MDM4-G variant results from an in-frame deletion of aa 27-124, encompassing the p53-binding domain (Fig. 2b). Interestingly this variant, which is unable to bind p53, still possesses inhibitory activity toward p53 although less pronounced than that of fl-MDM4. This inhibition has been attributed to the stabilization of MDM2 levels and consequently of its oncogenic properties.
###end p 62
###begin p 63
These data highlight the complexity of the function of MDM4 variants that might rely on the alteration of the activity of other oncogenic proteins, as MDM2 and/or MDM4, rather than on intrinsic tumor promoting properties.
###end p 63
###begin title 64
MDM4-211
###end title 64
###begin p 65
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R68">68</xref>
###xml 217 221 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4</italic>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2b</xref>
###xml 333 335 333 335 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F2">2b</xref></bold>
###xml 1462 1464 1462 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R68">68</xref>
###xml 25 30 <span type="species:ncbi:9606">human</span>
MDM4-211 is a variant of human MDM4 identified in a thyroid tumor cell line [68]. This form derives from an aberrant splicing event between the canonical donor site in exon 2 and a cryptic acceptor site in exon 11 of MDM4 fl-mRNA. The resulting protein contains the first 26 amino acids and the last 138 amino acids of fl-MDM4 (Fig. 2b). For this protein too, as for MDM4-S, the predicted molecular weight does not correspond to the molecular weight observed in SDS-PAGE suggesting the presence of covalent modifications. MDM4-211 does not bind p53 because of the almost complete loss of the p53 binding domain. Indeed, direct activity of MDM4-211 toward the p53 oncosuppressor was not observed. On the contrary, MDM4-211 binds MDM2 through the C-terminus and stabilizes its protein levels by increasing the protein half life. Particularly, MDM4-211 seems to function as an inhibitor of MDM2 degradative function causing stabilization of p53 in addition to MDM2. Interestingly, the resulting p53 is transcriptionally inactive, raising the hypothesis that MDM4-211 may stabilize an inactive complex, MDM2-p53, by binding to it. The oncogenic properties of MDM4-211 might therefore rely on both stabilization of the oncoprotein MDM2 and inactivation of p53. In fact, colony assays have shown transforming potential ability of MDM4-211 both in a p53-null and wild type background supporting the hypothesis that the primary target of MDM4-211 is the oncogenic MDM2 [68].
###end p 65
###begin p 66
###xml 17 25 17 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4-211</italic>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R68">68</xref>
###xml 98 106 98 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4-211</italic>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R65">65</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R65">65</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R68">68</xref>
###xml 612 620 612 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4-211</italic>
###xml 662 666 662 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4</italic>
###xml 754 758 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4</italic>
###xml 3 8 <span type="species:ncbi:9606">human</span>
In human tumors, MDM4-211 was found in 2 out of 16 non-small-cell lung cancers [68]. In addition, MDM4-211 was found with a frequency of 18% in a group of 83 papillary thyroid carcinomas (PTC) [65]. No correlation with tumor properties has been reported. In most of the tumors expressing MDM4-211, MDM2 showed enhanced protein levels not associated to gene amplification, confirming the molecular model proposed. Importantly, MDM4-211 was never found in normal tissues, suggesting it derives from an aberrant event occurring only in tumor cells [65, 68]. In analogy to what happens for MDM4-S, the expression of MDM4-211 does not correlate with the levels of fl-MDM4 transcript suggesting the independency of this splicing event from the abundance of fl-MDM4 transcript.
###end p 66
###begin p 67
Besides the effect toward MDM2, MDM4-211 maintains the interaction with fl-MDM4. Thus, some of its activities could also rely on the deregulation and/or squelching of other factors from fl-MDM4. Particularly, MDM4-211 maintains the 14-3-3 binding site and might therefore decrease the interaction of MDM4 with these proteins and consequently impair the MDM4 degradation mediated by this association, thus enhancing the oncogenic potential of fl-MDM4.
###end p 67
###begin title 68
MDM4-XALT1 and -XALT2
###end title 68
###begin p 69
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4</italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XALT1</italic>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XALT2</italic>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R69">69</xref>
###xml 209 214 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XALT1</italic>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4</italic>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XALT2</italic>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2b</xref>
###xml 357 359 357 359 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F2">2b</xref></bold>
###xml 387 392 387 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XALT1</italic>
###xml 601 606 601 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XALT2</italic>
###xml 94 99 <span type="species:ncbi:9606">human</span>
In 2006, along the analysis of MDM2 alternative transcripts induced by UV irradiation in some human tumor cell lines, Lozano's group found out two alternative transcripts of MDM4, called XALT1 and XALT2 [69]. XALT1 derives from a splicing event between exon 5 and exon 10 of MDM4 fl-mRNA while XALT2 derives from a splicing between exon 3 and exon 10 (Fig. 2b). The predicted protein of XALT1 transcript possesses only the p53 binding domain. As a consequence, it is presumed to bind p53 and to suppress its transcriptional activity as occurs for the MDMX-S form. Conversely, the predicted protein of XALT2 transcript lacks the p53 binding domain and retains the COOH-terminal RING finger domain. Thus, this variant may bind fl-MDM4 and/or MDM2 and regulate their function. Interestingly, a transcript analogous to XALT2 has been described for MDM2 under the same conditions.
###end p 69
###begin p 70
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R70">70</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R69">69</xref>
These forms have been evidenced in different tumor cell lines. Their presence has been supposed to be a further layer of regulation of the p53-MDM2-MDM4 network in response to DNA damage. However, their presence after high doses of UV irradiation, which probably induce an apoptotic response, might also represent a survival response of tumor cells. Indeed, XALT1 might limit p53 activity while XALT2 might stabilize MDM2 protein levels and its antiapoptotic function [70]. The expression of these variants in non tumor cells might help to discriminate their function [69].
###end p 70
###begin title 71
###xml 25 30 <span type="species:ncbi:9606">Human</span>
Role of MDM4 Variants in Human Tumorigenesis
###end title 71
###begin p 72
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R71">71</xref>
The two members of the MDM family, MDM2 and MDM4 are characterized by the presence of a large number of splicing variants. For MDM2, 40 splice variants have been described [71] while six for the younger MDM4 have been identified. It has to be pointed out that for majority of these variants it is presently unknown whether they are translated into protein.
###end p 72
###begin p 73
###xml 264 268 264 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4</italic>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM2</italic>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R69">69</xref>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM2</italic>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R71">71</xref>
###xml 511 515 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDM4</italic>
Most of them have been recognized only in tumor samples and/or tumor cell lines. The reasons for a so frequent rearrangement of fl-mRNA splicing have not been provided. Some conserved sequence blocks for the splicing factors SC35 and SRp40 have been recognized in MDM4 and MDM2 but their function has not been investigated [69]. Similarly, in MDM2 some regions have been identified having high sequence homology and repeated occurrence (at least 4 times) [71]. However, the same regions are not recognizable in MDM4, thus not supporting a role for them at least in MDM4 splicing.
###end p 73
###begin p 74
###xml 226 233 226 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R72">72</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="R73">73</xref>
The recovery of some of the MDM4 variants, as well as of MDM2, in tumor cells and the analysis of their activity suggest that they may possess tumorigenic activity. For MDM2 some studies have indeed confirmed such activity in in vivo models [72,73]. For MDM4 similar models have not yet been developed.
###end p 74
###begin p 75
The discrimination of the oncogenic activities of these variants represents a difficult task. Indeed, their ability to bind and modify the function of their fl-counterparts, MDM2 and MDM4, intertwine their direct activity towards targets as p53 and affects the functional outcome of their expression. Thus, their activity may reside not only in their intrinsic properties but also in their ability to squelch out binding partners from MDM4/MDM2 and/or sequester the fl-proteins. In addition, the ratio of expression levels of these variants to those of fl-MDM proteins represents an additional variable in the study of their function. Indeed, analysis of tumor samples has shown the absence of any correlation between the levels of MDM4-S or MDM4-211 and fl-MDM4 transcript suggesting independency of their expression.
###end p 75
###begin p 76
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2a</xref>
###xml 191 193 191 193 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F2">2a</xref></bold>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">b</xref>
###xml 198 199 198 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F2">b</xref></bold>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 676 677 676 677 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="fig" rid="F1">1</xref></bold>
Interestingly, the MDM4 variants may be roughly distinguished in two groups: one preserving the p53 binding domain and the other preserving the COOH-terminus where MDM2 binding resides (Fig. 2a and b). With the exception of MDM4-A, the presence of one of these two portions appears to exclude the other. Although, the number of MDM4 variants identified thus far is too low to draw out any certain prediction, this observation might suggest that the central part of MDM4 exerts a regulatory function counterselected by transformation process. In agreement with this hypothesis, most of the MDM4 modifications thus far identified reside in the central part of the protein (Fig. 1).
###end p 76
###begin p 77
Analysis of the association of MDM4 variant expression with tumor properties has evidenced some significant correlations. These data may suggest a potential role of these MDM4 forms as molecular predictors of cancer features.
###end p 77
###begin p 78
Finally, an important issue raised by the identification of MDM4 and MDM2 variants is the need to develop accurate detection systems able to distinguish the fl-MDM molecules from their variants in the tumor samples both at the levels of mRNA as well as of protein. This requires the development of specific primers for RT-PCR and most importantly of specific antibodies in immunohistochemistry. This aspect seems of particular relevance in view of the lack of a correlation between the presence of these variants and the levels of the full-length transcript.
###end p 78
###begin title 79
CONCLUSIONS
###end title 79
###begin p 80
###xml 233 240 233 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
The discovery of MDM4 in 1996 has added a further layer of complexity to the regulation of p53 by MDM2. Nowadays, the different molecular activities exerted by the two MDM proteins toward p53 have originated at least three models of in vivo function, indicating the difficulties to join in an unmatched view all experimental data thus far provided. The uncovering of different variants of both MDM2 and MDM4 increases even more the complexity of this picture that requires additional investigation of MDM function, especially along the tumorigenic process. It represents an interesting challenge in the investigation of tumor biology and of particular relevance in view of the proposal of targeted therapies toward specific molecules, such as those based on the release of p53 oncosuppressive function from MDM constraint.
###end p 80
###begin title 81
ACKNOWLEDGEMENTS
###end title 81
###begin p 82
This work was supported by grants from AIRC (Associazione Italiana Ricerca sul Cancro) and from Ministero della Salute.
###end p 82
###begin title 83
REFERENCES
###end title 83
###begin article-title 84
MDMX:a novel p53-binding protein with some functional properties of MDM2
###end article-title 84
###begin article-title 85
###xml 36 41 <span type="species:ncbi:9606">human</span>
Isolation and identification of the human homolog of a new p53-binding protein, Mdmx
###end article-title 85
###begin article-title 86
###xml 42 47 <span type="species:ncbi:9606">human</span>
Flexible lid to the p53-binding domain of human Mdm2: Implications for p53 regulation
###end article-title 86
###begin article-title 87
A genetic approach to mapping the p53 binding site in the MDM2 protein
###end article-title 87
###begin article-title 88
Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity
###end article-title 88
###begin article-title 89
Comparative study of the p53-mdm2 and p53-MDMX interfaces
###end article-title 89
###begin article-title 90
###xml 17 22 <span type="species:ncbi:9606">human</span>
Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain
###end article-title 90
###begin article-title 91
Molecular basis for the inhibition of p53 by Mdmx
###end article-title 91
###begin article-title 92
Targeting the Conformational Transitions of MDM2 and MDMX: Insights into Dissimilarities and Similarities of p53 Recognition
###end article-title 92
###begin article-title 93
Inactivation of the p53 pathway in retinoblastoma
###end article-title 93
###begin article-title 94
MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin
###end article-title 94
###begin article-title 95
Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3
###end article-title 95
###begin article-title 96
###xml 48 53 <span type="species:ncbi:9606">human</span>
Hdmx modulates the outcome of p53 activation in human tumor cells
###end article-title 96
###begin article-title 97
Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
###end article-title 97
###begin article-title 98
Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase
###end article-title 98
###begin article-title 99
Mdmx as an essential regulator of p53 activity
###end article-title 99
###begin article-title 100
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
###end article-title 100
###begin article-title 101
Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53
###end article-title 101
###begin article-title 102
The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity
###end article-title 102
###begin article-title 103
An essential function of the extreme C-terminus of MDM2 can be provided by MDMX
###end article-title 103
###begin article-title 104
Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2
###end article-title 104
###begin article-title 105
Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein
###end article-title 105
###begin article-title 106
MDM2 interacts with MDMX through their RING finger domains
###end article-title 106
###begin article-title 107
RING domain-mediated interaction is a requirement for MDM2's E3 ligase activity
###end article-title 107
###begin article-title 108
Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans
###end article-title 108
###begin article-title 109
Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
###end article-title 109
###begin article-title 110
Structure and ubiquitin interactions of the conserved zinc finger domain of Npl4
###end article-title 110
###begin article-title 111
Ubiquitin interactions of NZF zinc fingers
###end article-title 111
###begin article-title 112
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts
###end article-title 112
###begin article-title 113
Modification of MDMX by sumoylation
###end article-title 113
###begin article-title 114
Phosphorylation of MdmX by CDK2/Cdc2(p34) is required for nuclear export of Mdm2
###end article-title 114
###begin article-title 115
Regulation of p53-MDMX interaction by casein kinase 1 alpha
###end article-title 115
###begin article-title 116
ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage
###end article-title 116
###begin article-title 117
Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage
###end article-title 117
###begin article-title 118
Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage
###end article-title 118
###begin article-title 119
14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation
###end article-title 119
###begin article-title 120
Phosphorylation of MDMX mediated by Akt leads to stabilization and induces 14-3-3 binding
###end article-title 120
###begin article-title 121
DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation
###end article-title 121
###begin article-title 122
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53
###end article-title 122
###begin article-title 123
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development
###end article-title 123
###begin article-title 124
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
mdmx is a negative regulator of p53 activity in vivo
###end article-title 124
###begin article-title 125
###xml 28 36 28 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
###end article-title 125
###begin article-title 126
MDM2 and MDMX bind and stabilize the p53-related protein p73
###end article-title 126
###begin article-title 127
MDM2 and MDMX can interact differently with ARF and members of the p53 family
###end article-title 127
###begin article-title 128
Hdmx and Mdm2 can repress transcription activation by p53 but not by p63
###end article-title 128
###begin article-title 129
Mdm2 and Mdm4 loss regulates distinct p53 activities
###end article-title 129
###begin article-title 130
The E2F-1 transcription factor is negatively regulated by its interaction with the MDMX protein
###end article-title 130
###begin article-title 131
MdmX represses E2F1 transactivation
###end article-title 131
###begin article-title 132
A transcriptionally inactive E2F-1 targets the MDM family of proteins for proteolytic degradation
###end article-title 132
###begin article-title 133
Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2
###end article-title 133
###begin article-title 134
ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation
###end article-title 134
###begin article-title 135
DNA damage induces MDMX nuclear translocation by p53-dependent and -independent mechanisms
###end article-title 135
###begin article-title 136
MDM2 and MDMX can interact differently with ARF and members of the p53 family
###end article-title 136
###begin article-title 137
MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation
###end article-title 137
###begin article-title 138
MdmX inhibits ARF mediated Mdm2 sumoylation
###end article-title 138
###begin article-title 139
MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2
###end article-title 139
###begin article-title 140
MdmX inhibits Smad transactivation
###end article-title 140
###begin article-title 141
MDMX inhibits the p300/CBP-mediated acetylation of p53
###end article-title 141
###begin article-title 142
Effects of MdmX on Mdm2-mediated downregulation of pRB
###end article-title 142
###begin article-title 143
MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins
###end article-title 143
###begin article-title 144
Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53
###end article-title 144
###begin article-title 145
A novel MDMX transcript expressed in a variety of transformed cell lines encodes a truncated protein with potent p53 repressive activity
###end article-title 145
###begin article-title 146
Identification of a domain within MDMX-S that is responsible for its high affinity interaction with p53 and high-level expression in mammalian cells
###end article-title 146
###begin article-title 147
Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis
###end article-title 147
###begin article-title 148
###xml 12 17 <span type="species:ncbi:9606">human</span>
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties
###end article-title 148
###begin article-title 149
Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification
###end article-title 149
###begin article-title 150
Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2
###end article-title 150
###begin article-title 151
###xml 56 61 <span type="species:ncbi:9606">human</span>
Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization
###end article-title 151
###begin article-title 152
Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4
###end article-title 152
###begin article-title 153
Mdm2: p53's lifesaver?
###end article-title 153
###begin article-title 154
###xml 50 55 <span type="species:ncbi:9606">human</span>
Alternative and aberrant splicing of MDM2 mRNA in human cancer
###end article-title 154
###begin article-title 155
Tumor promotion by Mdm2 splice variants unable to bind p53
###end article-title 155
###begin article-title 156
An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis
###end article-title 156
###begin p 157
###xml 125 132 125 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Scheme of MDM4 protein domains and of regions involved in protein-protein interaction. The interaction proteins validated by in vivo binding assays are shown. Bold characters represent validated serine phosphorylation sites. Italic characters represent lysine sumoylation sites.
###end p 157
###begin p 158
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 142 143 142 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
(a) Scheme of MDM4 mRNA organization in exons (according to the GeneBank NM 002393) paralleled to the structure of the MDM4 protein regions. (b) Scheme of mRNA of MDM4 variants.
###end p 158

